Onconetix, Inc.
ONCO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782107
No open-market purchases or sales by Onconetix, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.9K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Onconetix, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +7 vs. Q1 2023
- Shares held
- 2.39M
- +770.6K (+47.6%) vs. Q1 2023
- Total value
- $2.70M
- +$967.5K (+55.8%) vs. Q1 2023
- New holders
- 9
- 7 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $73.9K |
| Q1 2026 | 5 | $24.9K |
| Q4 2025 | 7 | $95.3K |
| Q3 2025 | 8 | $303.7K |
| Q2 2025 | 7 | $43.0K |
| Q1 2025 | 13 | $26.7K |
| Q4 2024 | 11 | $241.7K |
| Q3 2024 | 8 | $3.23M |
| Q2 2024 | 20 | $491.6K |
| Q1 2024 | 17 | $367.8K |
| Q4 2023 | 22 | $478.6K |
| Q3 2023 | 19 | $1.82M |
| Q2 2023 | 20 | $2.70M |
| Q1 2023 | 13 | $1.73M |
| Q4 2022 | 18 | $2.13M |
| Q3 2022 | 19 | $4.03M |
| Q2 2022 | 10 | $2.37M |
| Q1 2022 | 13 | $25.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Onconetix, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Financial Group Inc | 1,440,927 | $1.63M | 0.50% | +500,165+53.2% | Added |
| Cetera Advisor Networks LLC | 273,700 | $309.3K | 0.00% | +2,900+1.1% | Added |
| Vanguard Group Inc | 177,283 | $200.3K | 0.00% | +400+0.2% | Added |
| Bank of America Corp | 125,000 | $141.3K | 0.00% | +125,000 | New |
| Fifth Third Bancorp | 96,196 | $108.7K | 0.00% | +62,521+185.7% | Added |
| Geode Capital Management, LLC | 53,740 | $60.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 53,561 | $60.5K | 0.00% | −16,680−23.7% | Reduced |
| State Street Corp | 38,293 | $43.3K | 0.00% | +38,293 | New |
| Susquehanna International Group, LLP | 35,767 | $40.4K | 0.00% | +35,767 | New |
| Bank of New York Mellon Corp | 27,085 | $30.6K | 0.00% | −193−0.7% | Reduced |
| Bahl & Gaynor Inc | 23,815 | $26.9K | 0.00% | +11,665+96.0% | Added |
| Virtu Financial LLC | 14,889 | $17.0K | 0.00% | +14,889 | New |
| Two Sigma Advisers, LP | 11,100 | $12.5K | 0.00% | −4,200−27.5% | Reduced |
| Cubist Systematic Strategies, LLC | 10,024 | $11.3K | 0.00% | +10,024 | New |
| Tower Research Capital LLC (TRC) | 7,014 | $7.93K | 0.00% | +3,963+129.9% | Added |
| UBS Group AG | 1,500 | $1.70K | 0.00% | +1,500 | New |
| Aspire Private Capital, LLC | 600 | $678 | 0.00% | +600 | New |
| O'Dell Group, LLC | 115 | $130 | 0.00% | +115 | New |
| Wells Fargo & Company | 38 | $43 | 0.00% | +3+8.6% | Added |
| Royal Bank of Canada | 156 | $0 | 0.00% | +156 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,760−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −4,492−100.0% | Sold out |